Lilo Sarit, Zheng Ying, Bliska James B
Department of Molecular Genetics and Microbiology, Center for Infectious Diseases, State University of New York at Stony Brook, New York 11794-5222, USA.
Infect Immun. 2008 Sep;76(9):3911-23. doi: 10.1128/IAI.01695-07. Epub 2008 Jun 16.
Pathogenic Yersinia species utilize a type III secretion system (T3SS) to translocate effectors called Yersinia outer proteins (Yops) into infected host cells. Previous studies demonstrated a role for effector Yops in the inhibition of caspase-1-mediated cell death and secretion of interleukin-1beta (IL-1beta) in naïve macrophages infected with Yersinia enterocolitica. Naïve murine macrophages were infected with a panel of different Yersinia pestis and Yersinia pseudotuberculosis strains to determine whether Yops of these species inhibit caspase-1 activation. Cell death was measured by release of lactate dehydrogenase (LDH), and enzyme-linked immunosorbent assay for secreted IL-1beta was used to measure caspase-1 activation. Surprisingly, isolates derived from the Y. pestis KIM strain (e.g., KIM5) displayed an unusual ability to activate caspase-1 and kill infected macrophages compared to other Y. pestis and Y. pseudotuberculosis strains tested. Secretion of IL-1beta following KIM5 infection was reduced in caspase-1-deficient macrophages compared to wild-type macrophages. However, release of LDH was not reduced in caspase-1-deficient macrophages, indicating that cell death occurred independently of caspase-1. Analysis of KIM-derived strains defective for production of functional effector or translocator Yops indicated that translocation of catalytically active YopJ into macrophages was required for caspase-1 activation and cell death. Release of LDH and secretion of IL-1beta were not reduced when actin polymerization was inhibited in KIM5-infected macrophages, indicating that extracellular bacteria translocating YopJ could trigger cell death and caspase-1 activation. This study uncovered a novel role for YopJ in the activation of caspase-1 in macrophages.
致病性耶尔森氏菌利用III型分泌系统(T3SS)将称为耶尔森氏菌外蛋白(Yops)的效应蛋白转运到受感染的宿主细胞中。先前的研究表明,效应蛋白Yops在抑制小肠结肠炎耶尔森氏菌感染的未致敏巨噬细胞中半胱天冬酶-1介导的细胞死亡和白细胞介素-1β(IL-1β)分泌方面发挥作用。用一组不同的鼠疫耶尔森氏菌和假结核耶尔森氏菌菌株感染未致敏的小鼠巨噬细胞,以确定这些菌种的Yops是否抑制半胱天冬酶-1的激活。通过乳酸脱氢酶(LDH)释放来测量细胞死亡,并使用酶联免疫吸附测定法检测分泌的IL-1β来测量半胱天冬酶-1的激活。令人惊讶的是,与测试的其他鼠疫耶尔森氏菌和假结核耶尔森氏菌菌株相比,源自鼠疫耶尔森氏菌KIM菌株(如KIM5)的分离株表现出激活半胱天冬酶-1和杀死受感染巨噬细胞的异常能力。与野生型巨噬细胞相比,在半胱天冬酶-1缺陷的巨噬细胞中,KIM5感染后IL-1β的分泌减少。然而,在半胱天冬酶-1缺陷的巨噬细胞中LDH的释放并未减少,这表明细胞死亡独立于半胱天冬酶-1发生。对产生功能性效应蛋白或转运蛋白Yops有缺陷的KIM衍生菌株的分析表明,催化活性YopJ转运到巨噬细胞中是半胱天冬酶-1激活和细胞死亡所必需的。当在KIM5感染的巨噬细胞中抑制肌动蛋白聚合时,LDH的释放和IL-1β的分泌并未减少,这表明转运YopJ的细胞外细菌可触发细胞死亡和半胱天冬酶-1激活。这项研究揭示了YopJ在巨噬细胞中激活半胱天冬酶-1方面的新作用。